Nrf2 Inhibits the Progression of Parkinson’s Disease by Upregulating AABR07032261.5 to Repress Pyroptosis

References

• Kalia LV, Lang AE. Parkinson’s disease. Lancet. 2015;386:896–912. doi:10.1016/s0140-6736(14)61393-3
   PubMed Web of Science ®Google Scholar
• Raza C, Anjum R, Shakeel NUA. Parkinson’s disease: mechanisms, translational models and management strategies. Life Sci. 2019;226:77–90. doi:10.1016/j.lfs.2019.03.057
   PubMed Web of Science ®Google Scholar
• Ascherio A, Schwarzschild MA. The epidemiology of Parkinson’s disease: risk factors and prevention. Lancet Neurol. 2016;15:1257–1272. doi:10.1016/s1474-4422(16)30230-7
   PubMed Web of Science ®Google Scholar
• Emamzadeh FN, Surguchov A. Parkinson’s disease: biomarkers, treatment, and risk factors. Front Neurosci. 2018;12:612. doi:10.3389/fnins.2018.00612
   PubMed Web of Science ®Google Scholar
• Puschmann A. New genes causing hereditary Parkinson’s disease or Parkinsonism. Curr Neurol Neurosci Rep. 2017;17:66. doi:10.1007/s11910-017-0780-8
   PubMed Web of Science ®Google Scholar
• Trist BG, Hare DJ, Double KL. Oxidative stress in the aging substantia nigra and the etiology of Parkinson’s disease. Aging Cell. 2019;18:e13031. doi:10.1111/acel.13031
   PubMed Web of Science ®Google Scholar
• Puspita L, Chung SY, Shim JW. Oxidative stress and cellular pathologies in Parkinson’s disease. Mol Brain. 2017;10:53. doi:10.1186/s13041-017-0340-9
   PubMed Web of Science ®Google Scholar
• Zhong H, Hao L, Li X, Wang C, Wu X. Anti-inflammatory role of trilobatin on lipopolysaccharide-induced acute lung injury through activation of ampk/gsk3β-nrf2 pathway. Signa Vitae. 2020;16:160–166.
   Web of Science ®Google Scholar
• Morris G, Walker AJ, Berk M, Maes M, Puri BK. Cell death pathways: a novel therapeutic approach for neuroscientists. Mol Neurobiol. 2018;55:5767–5786. doi:10.1007/s12035-017-0793-y
   PubMed Web of Science ®Google Scholar
• Frank D, Vince JE. Pyroptosis versus necroptosis: similarities, differences, and crosstalk. Cell Death Differ. 2019;26:99–114. doi:10.1038/s41418-018-0212-6
   PubMed Web of Science ®Google Scholar
• Wang S, Yuan YH, Chen NH, Wang HB. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson’s disease. Int Immunopharmacol. 2019;67:458–464. doi:10.1016/j.intimp.2018.12.019
   PubMed Web of Science ®Google Scholar
• de la Vega MR, Chapman E, Zhang DD. NRF2 and the Hallmarks of cancer. Cancer Cell. 2018;34:21–43. doi:10.1016/j.ccell.2018.03.022
   PubMed Web of Science ®Google Scholar
• Tonelli C, Chio IIC, Tuveson DA. Transcriptional regulation by Nrf2. Antioxid Redox Signal. 2018;29:1727–1745. doi:10.1089/ars.2017.7342
   PubMed Web of Science ®Google Scholar
• Loboda A, Damulewicz M, Pyza E, Jozkowicz A, Dulak J. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73:3221–3247. doi:10.1007/s00018-016-2223-0
   PubMed Web of Science ®Google Scholar
• Ammal Kaidery N, Ahuja M, Thomas B. Crosstalk between Nrf2 signaling and mitochondrial function in Parkinson’s disease. Mol Cell Neurosci. 2019;101:103413. doi:10.1016/j.mcn.2019.103413
   PubMed Web of Science ®Google Scholar
• Zhao MW, Yang P, Zhao LL. Chlorpyrifos activates cell pyroptosis and increases susceptibility on oxidative stress-induced toxicity by miR-181/SIRT1/PGC-1alpha/Nrf2 signaling pathway in human neuroblastoma SH-SY5Y cells: implication for association between chlorpyrifos and Parkinson’s disease. Environ Toxicol. 2019;34:699–707. doi:10.1002/tox.22736
   PubMed Web of Science ®Google Scholar
• Rostamian Delavar M, Baghi M, Safaeinejad Z, et al. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson’s disease. Gene. 2018;662:54–65. doi:10.1016/j.gene.2018.04.010
   PubMed Web of Science ®Google Scholar
• Luo Y, Jiang Y, He Y, et al. Vina-ginsenoside R4 from panax ginseng leaves alleviates 6-OHDA-induced neurotoxicity in PC12 cells via the PI3K/Akt/GSK-3β signaling pathway. J Agric Food Chem. 2020;68:15239–15248. doi:10.1021/acs.jafc.0c06474
   PubMed Web of Science ®Google Scholar
• Ghahari L, Safari M, Rahimi Jaberi K, et al. Mesenchymal stem cells with granulocyte colony-stimulating factor reduce stress oxidative factors in Parkinson’s disease. Iran Biomed J. 2020;24:89–98. doi:10.29252/ibj.24.2.89
   PubMedGoogle Scholar
• Li J, Dai X, Zhou L, Li X, Pan D. Edaravone plays protective effects on LPS-induced microglia by switching M1/M2 phenotypes and regulating NLRP3 inflammasome activation. Front Pharmacol. 2021;12:691773. doi:10.3389/fphar.2021.691773
   PubMed Web of Science ®Google Scholar
• Boccella S, Iannotta M, Cristiano C, et al. Treatment with 2-pentadecyl-2-oxazoline restores mild traumatic brain injury-induced sensorial and neuropsychiatric dysfunctions. Front Pharmacol. 2020;11:91. doi:10.3389/fphar.2020.00091
   PubMed Web of Science ®Google Scholar
• Gao Y, Cui M, Zhong S, et al. Dihydroartemisinin ameliorates LPS-induced neuroinflammation by inhibiting the PI3K/AKT pathway. Metab Brain Dis. 2020;35:661–672. doi:10.1007/s11011-020-00533-2
   PubMed Web of Science ®Google Scholar
• Li Q, Shi N, Cai C, et al. The role of mitochondria in pyroptosis. Front Cell Dev Biol. 2020;8:630771. doi:10.3389/fcell.2020.630771
   PubMed Web of Science ®Google Scholar
• Liu S, Du J, Li D, et al. Oxidative stress induced pyroptosis leads to osteogenic dysfunction of MG63 cells. J Mol Histol. 2020;51:221–232. doi:10.1007/s10735-020-09874-9
   PubMed Web of Science ®Google Scholar
• Le X, Mu J, Peng W, et al. DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis. Theranostics. 2020;10:9495–9511. doi:10.7150/thno.45631
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li KS, Liu L, Li SL. MicroRNA132 promotes oxidative stress induced pyroptosis by targeting sirtuin 1 in myocardial ischaemia reperfusion injury. Int J Mol Med. 2020;45:1942–1950. doi:10.3892/ijmm.2020.4557
   PubMed Web of Science ®Google Scholar
• Fan X, Zhan E, Yao Y, et al. MiR-599 protects cardiomyocytes against oxidative stress-induced pyroptosis. Biomed Res Int. 2021;2021:3287053. doi:10.1155/2021/3287053
   PubMed Web of Science ®Google Scholar
• Diao C, Chen Z, Qiu T, et al. Inhibition of PRMT5 attenuates oxidative stress-induced pyroptosis via activation of the Nrf2/HO-1 signal pathway in a mouse model of renal ischemia-reperfusion injury. Oxid Med Cell Longev. 2019;2019:2345658. doi:10.1155/2019/2345658
   PubMed Web of Science ®Google Scholar
• Liu H, Chen Z, Weng X, et al. Enhancer of zeste homolog 2 modulates oxidative stress-mediated pyroptosis in vitro and in a mouse kidney ischemia-reperfusion injury model. FASEB J. 2020;34:835–852. doi:10.1096/fj.201901816R
   PubMed Web of Science ®Google Scholar
• Hughes MM, O’Neill LAJ. Metabolic regulation of NLRP3. Immunol Rev. 2018;281:88–98. doi:10.1111/imr.12608
   PubMed Web of Science ®Google Scholar
• Qiu Z, He Y, Ming H, et al. Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia/reoxygenation-induced injury through activating ROS-dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. J Diabetes Res. 2019;2019:8151836. doi:10.1155/2019/8151836
   PubMed Web of Science ®Google Scholar
• Lin Y, Luo T, Weng A, et al. Gallic acid alleviates gouty arthritis by inhibiting NLRP3 inflammasome activation and pyroptosis through enhancing Nrf2 signaling. Front Immunol. 2020;11:580593. doi:10.3389/fimmu.2020.580593
   PubMed Web of Science ®Google Scholar
• Long Y, Wang X, Youmans DT, Cech TR. How do lncRNAs regulate transcription? Sci Adv. 2017;3:eaao2110. doi:10.1126/sciadv.aao2110
   PubMed Web of Science ®Google Scholar
• Lv Q, Wang Z, Zhong Z, Huang W. Role of long noncoding RNAs in Parkinson’s disease: putative biomarkers and therapeutic targets. Parkinsons Dis. 2020;2020:5374307. doi:10.1155/2020/5374307
   PubMed Web of Science ®Google Scholar
• Bhattacharjee S, Li J, Dashwood RH. Emerging crosstalk between long non-coding RNAs and Nrf2 signaling. Cancer Lett. 2020;490:154–164. doi:10.1016/j.canlet.2020.07.011
   PubMed Web of Science ®Google Scholar
• Vuokila N, Aronica E, Korotkov A, et al. Chronic regulation of miR-124-3p in the perilesional cortex after experimental and human TBI. Int J Mol Sci. 2020;21. doi:10.3390/ijms21072418
   PubMed Web of Science ®Google Scholar
• Geng L, Liu W, Chen Y. miR-124-3p attenuates MPP (+)-induced neuronal injury by targeting STAT3 in SH-SY5Y cells. Exp Biol Med. 2017;242:1757–1764. doi:10.1177/1535370217734492
   PubMed Web of Science ®Google Scholar